US Patent 8968741 Anti-CD22 antibodies and immunoconjugates and methods of use
Patent 8968741 was granted and assigned to Genentech on March, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 6, 2013
Date of Patent
March 3, 2015
Patent Applicant
Patent Application Number
13760751
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8968741 Anti-CD22 antibodies and immunoconjugates and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
